This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Congenital malformation syndromes due to known exogenous causes, not elsewhere classified
Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
45 |
4. Check minimum number of eventsNone |
45 |
5. Include endpointsNone |
45 |
6. Filter based on genotype QC (FinnGen only) |
45 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q8
- Name in latin
- Syndromata malformationum congenitarum e causis externis notis non alibi classificata
Similar endpoints
↥List of similar endpoints to
Congenital malformation syndromes due to known exogenous causes, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Exclusion endpoint for clefts
- Other congenital malformations
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1153 | 503 | 650 |
| Only index persons | 998 | 447 | 551 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.01 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | - | 6.49 | 7.16 |
| Only index persons | 7.22 | 6.84 | 7.54 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 45 | 24 | 21 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 17.06 | 12.36 | 22.44 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
18
40
6.83
8.56
3.4
2.1
e6/l
0.6
1.3
—
9
19
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
16
41
5.50
6.36
3.8
2.1
e6/l
4.4
7.3
—
7
20
(3030467) Casts [#/volume] in Urine by Automated count
22
77
4.63
5.99
4.2
2.3
e6/l
0.2
0.3
0.14
17
57
(3042936) Bacteria identified in Isolate by Culture
12
29
5.28
4.98
2.2
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
16
55
3.96
4.26
6.8
3.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
27
134
3.54
4.12
9.4
5.1
umol/l
9.7
11.3
0.47
27
125
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
22
99
3.39
3.87
8.4
2.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
18
78
3.18
3.28
3.1
2.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
9
25
4.23
2.75
21.9
3.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
9
25
4.23
2.75
7.7
2.0
kpa
5.5
5.6
—
9
25
(3000850) Epithelial cells [#/volume] in Urine
15
64
3.02
2.75
2.9
2.0
e6/l
9.6
7.2
0.28
15
59
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
6
11
6.10
2.63
4.2
2.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
8
21
4.40
2.60
3.0
2.1
mmol/l
26.7
23.7
—
8
21
(3012544) pH of Venous blood
9
28
3.75
2.47
8.7
2.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
7
17
4.67
2.47
7.0
3.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
8
6.85
2.43
10.8
1.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
18
91
2.63
2.38
10.6
6.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
18
4.40
2.36
4.1
8.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
7
20
3.94
2.15
1.7
1.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
31
210
2.53
2.14
11.9
7.2
e9/l
4.4
3.6
1.20
24
185
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
10
5.47
2.13
1.6
1.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
5
10
5.47
2.13
37.4
3.8
%
94.4
94.5
—
5
10
(3002032) Base excess in Venous blood by calculation
8
27
3.37
2.05
9.6
2.4
mmol/l
3.7
1.5
—
8
16
(3033658) Prothrombin time (PT) actual/Normal
14
67
2.58
2.02
4.9
2.3
%
84.9
96.3
1.54
14
67
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
16
4.15
2.01
13.8
5.6
mmol/l
23.0
23.9
—
6
16
(3032080) INR in Blood by Coagulation assay
15
76
2.46
1.92
28.3
4.2
inr
1.6
1.1
—
6
27
(3001604) Monocytes [#/volume] in Blood
27
178
2.29
1.90
8.2
5.3
e9/l
0.6
0.5
0.69
20
164
(3006315) Basophils [#/volume] in Blood
27
179
2.27
1.86
8.2
5.2
e9/l
0.0
0.0
1.18
21
164
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
18
3.68
1.81
2.7
1.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
19
111
2.23
1.75
7.8
5.1
—
—
—
0
0
(3013512) EKG study
12
58
2.46
1.67
2.9
2.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
25
166
2.14
1.66
10.8
6.2
e9/l
0.0
0.0
0.00
16
135
(3036481) Cortisol [Moles/volume] in Serum or Plasma
7
26
2.99
1.66
2.9
2.2
nmol/l
449.6
422.3
—
7
26
(3022621) pH of Urine by Test strip
6
20
3.30
1.64
2.8
1.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
27
187
2.11
1.58
9.1
5.2
e9/l
0.2
0.2
0.50
22
171
(3019198) Lymphocytes [#/volume] in Blood
27
187
2.11
1.58
8.2
5.1
e9/l
1.9
2.1
0.40
22
173
(3025941) Bacteria identified in Stool by Culture
6
21
3.13
1.56
1.5
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
5
116
0.36
1.54
1.8
1.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
9
39
2.63
1.54
1.2
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
29
2.67
1.46
2.3
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
7
29
2.67
1.46
2.4
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
37
0.00
1.42
0.0
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
10
48
2.39
1.40
2.5
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
37
301
2.29
1.37
20.1
8.2
ml/min/173m2
98.4
98.2
0.01
30
229
(3014576) Chloride [Moles/volume] in Serum or Plasma
5
18
2.99
1.32
48.6
4.8
mmol/l
91.6
104.4
—
5
18
(3037467) Urinalysis macro (dipstick) panel - Urine
30
226
1.98
1.29
7.3
4.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
6
25
2.61
1.29
1.8
2.3
g/l
9.8
10.1
—
6
25
(3026008) Bacteria identified in Urine by Culture
15
90
2.00
1.24
4.7
2.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
33
0.00
1.22
0.0
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
20
2.68
1.18
1.4
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
12
68
2.04
1.14
2.3
1.5
%
1.5
1.3
0.56
12
62
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
13
79
1.91
1.02
3.7
2.4
u/l
49.0
55.5
0.89
13
72
(3044640) Blood type and Crossmatch panel - Blood
14
88
1.86
0.99
3.9
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
6
27
2.40
0.98
1.2
1.5
—
—
—
0
0
(3044889) 12 lead EKG panel
24
179
1.73
0.96
2.4
2.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
30
240
1.75
0.92
3.1
3.8
mm/h
11.5
8.2
0.41
25
224
(46235355) HIV 1 and 2 tests - Meaningful Use set
19
137
1.67
0.84
1.8
2.3
—
—
—
0
0
(3002256) Pathology report gross observation
0
25
0.00
0.82
0.0
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
25
0.00
0.82
0.0
1.7
—
286.9
—
0
8
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
5
24
2.21
0.77
8.0
4.3
u/l
244.0
211.4
—
5
24
(3011397) Hemoglobin [Presence] in Urine by Test strip
11
69
1.79
0.77
5.9
3.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
7
39
1.94
0.77
1.4
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
14
95
1.69
0.76
6.4
2.8
mmol/l
8.4
8.8
0.08
14
79
(1761868) Lipid panel - Serum or Plasma
8
120
0.60
0.67
3.5
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
29
1.81
0.66
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
36
318
1.66
0.65
24.0
9.6
%
13.5
13.2
0.56
36
311
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
5
30
1.75
0.63
2.6
2.0
%
22.4
28.0
—
5
30
(3003327) Ova and parasites identified in Stool by Light microscopy
0
21
0.00
0.62
0.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
36
1.77
0.59
1.5
2.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
38
1.67
0.57
2.0
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
6
39
1.62
0.55
1.3
1.2
—
—
—
0
0
(3015736) pH of Urine
17
131
1.48
0.53
7.1
2.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
11
77
1.57
0.51
1.7
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
20
160
1.45
0.51
9.8
4.1
estimate
0.0
0.0
—
5
35
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
10
69
1.58
0.49
3.8
1.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
14
105
1.48
0.49
1.4
1.4
g/l
2.0
2.0
—
7
62
(40761536) Microorganisms panel - Urine sediment
5
31
1.69
0.45
3.0
3.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
16
0.00
0.42
0.0
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
20
165
1.38
0.41
7.0
3.0
estimate
0.0
0.0
—
5
36
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
18
146
1.39
0.41
2.5
2.6
ug/l
42.4
59.6
0.73
18
139
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
30
328
0.74
0.32
3.3
3.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
15
122
1.34
0.32
1.6
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
18
152
1.31
0.30
9.3
3.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
14
114
1.33
0.30
1.7
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
19
164
1.27
0.26
7.1
2.9
estimate
0.0
0.0
—
5
36
(36660697) Celiac disease serology panel - Serum
5
38
1.35
0.24
1.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
5
41
1.25
0.23
1.6
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
32.0
—
0
11
(3004588) Protein electrophoresis panel - Serum or Plasma
0
10
0.00
0.21
0.0
7.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
6
47
1.32
0.21
1.5
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
33
308
1.27
0.21
5.0
3.4
mmol/l
2.7
2.8
0.27
28
285
(3000764) Benzodiazepines [Presence] in Urine
6
52
1.18
0.20
1.5
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
52
1.18
0.20
1.5
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
52
1.18
0.20
1.5
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
52
1.18
0.20
1.5
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
15
130
1.23
0.19
8.4
2.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
7
61
1.17
0.18
1.3
1.4
mg/l
1.9
0.6
—
7
39
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
13
114
1.20
0.14
2.1
1.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
60
0.81
0.09
3.2
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
5
63
0.77
0.09
2.4
2.7
ug/g
131.5
111.0
—
5
44
(40761511) CBC panel - Blood by Automated count
39
378
1.24
0.08
26.2
7.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
73
0.79
0.08
1.2
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
11
100
1.13
0.06
6.7
2.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
35
347
1.04
0.00
22.1
8.7
%
37.8
41.2
0.93
29
296
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
117
1.03
0.00
2.3
2.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
123
0.97
0.00
2.6
2.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
11
105
1.06
0.00
1.4
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
7
74
0.94
0.00
9.6
5.8
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
118.9
—
0
6
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
72
0.97
0.00
2.6
2.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
8
86
0.92
0.00
1.5
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
0.0
—
0
5
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
7.7
—
0
5
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
2.0
—
0
5
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
29.6
—
0
5
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
3.1
—
0
5
(3037756) Immunofixation for Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
0.0
—
0
5
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
6.4
—
0
5
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
0.0
—
0
5
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
2.7
—
0
5
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
4.2
—
1.1
—
0
5
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
6.6
—
38.9
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED – Congenital malformation syndromes due to known exogenous causes, not elsewhere classified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data